Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.07.03.498548

3D-Printing in Radiation Oncology: Development and Validation of Custom 3D-Printed Brachytherapy Alignment Device and Phantom

Abstract

Brachytherapy seeks to treat cancer through insertion of radioactive sources aligned by needles within standardized blocking templates. However, many patients have anatomy that does not conform to standard tools. We created a 3D printed device to provide customized needle alignment for a patient. Device was validated through CT scan and treatment plan creation on a custom anatomical phantom based on patient data. CT scan of a cervix tumor from anonymized patient data was used to develop a 3D printed brachytherapy alignment tool and phantom anatomical mold. Multiple materials were evaluated to match patient anatomy in density and Hounsfield Units present on CT scan, with additional considerations for toxicity, compliance, and practicality. Alignment device and molds were developed in PLA. Silicone of T20 hardness was used to create relevant anatomical organs (Uterus, Rectum, Bladder). Tumor tissue was mimicked by addition of 1CC of Iodine contrast agent to silicone. Device and needles were arranged, inserted into anatomical phantom, and scanned by CT to mimic brachytherapy procedure. 3D printed Silicone uterus of 1.08 g/cm^3 and 40 HU mimicked human uterus on CT scan. Constructed uterus dimensions of 6.5 cm x 5.5 cm x 3.3 cm were verified on imaging to be within + 1 mm of original patient scan. The 1 CC of contrast agent provided sufficient differentiation of "tumor" ring from "tissue." CT scan and treatment plan creation verified that the alignment device provided correction insertion of needles into the phantom tumor tissue and uterus. This pilot study provides a potential methodology to develop future anatomical phantoms and alignment devices from CT scans of patient data. Additional modifications could make this a viable training tool for future residents and medical students to learn brachytherapy. Key PointsO_LI3D printing can be leveraged to create a Brachytherapy alignment device from patients anatomy. C_LIO_LIAnatomical phantom can be generated from 3D printing for use testing device or for training. C_LIO_LIRelevant materials to create phantom that mimic patients anatomy on CT scan. C_LIO_LIGeneration of a treatment plan based on CT scan was able to validate device and phantom C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Provenzano, D. J., Aghdam, H., Goyal, S., Loew, M., Rao, Y.. 2022-07-04. 3D-Printing in Radiation Oncology: Development and Validation of Custom 3D-Printed Brachytherapy Alignment Device and Phantom. https://doi.org/10.1101/2022.07.03.498548

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Comparative study of chlorophyll measurement in Physcomitrium patens moss using a conventional microscope adapted for combined 2D+1D imaging and spectral analysis

Imaging spectroscopy often requires expensive and complex equipment. Here we show a simple procedure for attaching a standard miniature fiber spectrometer to a conventional microscope, allowing easy integration of 2D imaging with 1D high-resolution spectral measurements. This combination provides much of the benefit of a full imaging spectrometer without the large equipment investment, and we provide instructions for modifying microscopes to this setup and the present measurements of living cells that demonstrate their performance. Using this setup, we compare the quantitative measurement of chlorophyll concentration in Physcomitrium patens moss using color imaging and spectral sampling.

bioengineering↗

De novo designed single-domain antibodies protect against lethal cobra venom neurotoxicity in vivo

Generative protein design can now rapidly produce de novo binders with high affinity and functional activity against a wide range of targets, including lethal snake venom toxins. However, so far most reported successes rely on new-to-nature scaffolds with limited therapeutic precedent. Single-domain antibodies (VHHs) offer a clinically validated alternative scaffold that can bind and neutralize long-chain -neurotoxins, which are some of the most lethal components in snake venoms. Here we compare three recently established de novo design models with VHH-design capabilities (Germinal, RFantibody, and BoltzGen) for their ability to generate VHHs against the neurotoxin -cobratoxin from the monocled cobra (Naja kaouthia). Using standardized model inputs and evaluation criteria based on AlphaFold3 interface confidence (ipTM) and RMSD self-consistency, we find that Germinal was the only method to generate designs passing stringent in silico criteria for experimental testing. We therefore performed a larger Germinal design campaign employing three different VHH frameworks and experimentally validated 46 designs in vitro. Of these, 42 expressed as soluble proteins and we identified four binding hits derived from two of the three tested frameworks. Of the four binders, two lead candidates were further characterized and demonstrated high affinity (KDs of 4.1 nM and 10.8 nM), monomeric behavior and low polyreactivity, indicating favorable biophysical and developability properties, as well as functional toxin neutralization in vitro. To assess their therapeutic potential we investigated their ability to protect against -cobratoxin toxicity in vivo. Both candidates fully protected mice after -cobratoxin challenge, with 100% survival compared to a lethal control. One candidate also retained notable neutralization capacity against whole venom of Naja kaouthia with a survival of 56%, while the other protected 22% when tested in a rescue setting. Together, we demonstrate that de novo VHH design can generate high affinity single-domain antibodies with in vivo protection against lethal cobra venom neurotoxicity, and provide practical insights into method- and framework-dependent performance.

bioengineering↗

Simple Feedback for Complex Movement: Capturing Whole-Limb Reorganization during Single-IMU Gait Retraining

Clinical gait retraining typically relies on multi-sensor arrays and high-dimensional feedback displays, imposing setup and interpretation burdens that limit routine clinical deployment. We developed a single-IMU visual biofeedback system that delivers real-time feedback of Lower Limb Trajectory Error (LLTE), a composite kinematic error metric integrating knee position and shank angle across the stance phase. Twenty able-bodied adults walked on a treadmill under two visual biofeedback targets (flexed-knee, extended-knee) while receiving either corrected (n=10) or uncorrected (n=8) feedback, where the correction accounted for limb orientation at initial contact. LLTE and stance-phase knee kinematics adapted consistently under the flexed-knee target for both feedback groups, with feedback formulation moderating the temporal trajectory of change. Adaptation toward the extended-knee target was limited, likely because participants were already operating near terminal knee extension and because the scalar error metric provided limited directional information for correction. Ankle range of motion (ROM) changed significantly across the stance phase under both target conditions, while hip ROM did not. Multiscale multivariate sample entropy (MSMVSE) increased monotonically with time scale across all conditions, with no statistically distinguishable difference between corrected and uncorrected feedback. These results suggest that single-IMU LLTE biofeedback can modify gait mechanics and that adaptation was expressed across multiple lower-limb segments rather than through changes at a single joint.

bioengineering↗